Meloxicam for skin cancer surgery pain
Treatments studied
Part of Cancer, Pain, Skin clinical trials.
This study tests if meloxicam, an anti-inflammatory painkiller, helps control pain after Mohs surgery for skin cancer. It aims to reduce the need for stronger opioid pain medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for Mohs surgery to remove skin cancer.
- You are not pregnant or planning to become pregnant.
- You do not have chronic liver disease (like hepatitis or cirrhosis).
- You do not have chronic kidney disease stage 3 or worse.
- You do not have a history of stomach ulcers, GI bleeding, or aspirin-sensitive asthma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new pain medication (suzetrigine) to a common pain reliever (Norco) for people recovering from Mohs micrographic surgery, a specialized procedure to remove skin cancer. The goal is to see if the new medication works better and is safer for post-surgery pain.
This study tests local anesthetics (numbing medicines) used during Mohs micrographic surgery, a specialized procedure for skin cancer. Researchers want to understand how well these numbing agents work and improve patient comfort during the procedure.
This study compares two common pain relievers, meloxicam and ibuprofen, for managing pain after wisdom tooth removal in adults. If you need to have a partially or fully visible wisdom tooth taken out, this trial can help find which medication works better for you.
This trial tests whether EMLA cream can reduce pain from injections needed to map lymph nodes for certain skin cancers. If you are scheduled for lymphoscintigraphy and sentinel lymph node biopsy, you may be eligible.
This trial is testing whether the pain reliever celecoxib (Celebrex) can help control pain after a specific type of salivary gland surgery called superficial parotidectomy. If you're having this surgery, you may be able to join and take celecoxib for pain rather than other common pain medicines.
This trial compares a new painkiller combination (Maxigesic) with standard pain relief for patients recovering from minimally invasive stomach cancer surgery. The goal is to see if Maxigesic provides better pain control with fewer side effects.
Hear when a new Postoperative Pain, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.